HomeCompareUNVC vs MRK

UNVC vs MRK: Dividend Comparison 2026

UNVC yields 80000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UNVC wins by $5.2077213163602945e+25M in total portfolio value
10 years
UNVC
UNVC
● Live price
80000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.2077213163602945e+25M
Annual income
$51,949,472,569,259,090,000,000,000,000,000.00
Full UNVC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — UNVC vs MRK

📍 UNVC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUNVCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UNVC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UNVC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UNVC
Annual income on $10K today (after 15% tax)
$6,800,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,157,051,683,870,220,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, UNVC beats the other by $44,157,051,683,870,220,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UNVC + MRK for your $10,000?

UNVC: 50%MRK: 50%
100% MRK50/50100% UNVC
Portfolio after 10yr
$2.6038606581801473e+25M
Annual income
$25,974,736,284,629,546,000,000,000,000,000.00/yr
Blended yield
99.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

UNVC
No analyst data
Altman Z
-2011.4
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UNVC buys
0
MRK buys
0
No recent congressional trades found for UNVC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUNVCMRK
Forward yield80000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5.2077213163602945e+25M$56.8K
Annual income after 10y$51,949,472,569,259,090,000,000,000,000,000.00$9,798.13
Total dividends collected$5.206883835920424e+25M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UNVC vs MRK ($10,000, DRIP)

YearUNVC PortfolioUNVC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$8,010,700$8,000,000.00$11,206$366.19+$8.00MUNVC
2$5,997,879,860$5,989,308,411.21$12,650$502.35+$5997.87MUNVC
3$4,197,442,177,404$4,191,024,445,953.32$14,407$694.19+$4197442.16MUNVC
4$2,745,581,773,359,261$2,741,090,510,229,439.00$16,585$967.82+$2745581773.34MUNVC
5$1,678,610,723,842,080,800$1,675,672,951,344,586,500.00$19,342$1,363.89+$1678610723842.06MUNVC
6$959,257,110,940,495,000,000$957,460,997,465,984,000,000.00$22,913$1,947.19+$959257110940495.00MUNVC
7$512,381,218,321,420,100,000,000$511,354,813,212,713,760,000,000.00$27,662$2,823.89+$512381218321420096.00MUNVC
8$255,816,465,068,545,120,000,000,000$255,268,217,164,941,240,000,000,000.00$34,159$4,173.35+$255816465068545114112.00MUNVC
9$119,383,733,031,653,200,000,000,000,000$119,110,009,414,029,840,000,000,000,000.00$43,337$6,308.80+$1.193837330316532e+23MUNVC
10$52,077,213,163,602,950,000,000,000,000,000$51,949,472,569,259,090,000,000,000,000,000.00$56,776$9,798.13+$5.2077213163602945e+25MUNVC

UNVC vs MRK: Complete Analysis 2026

UNVCStock

Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.

Full UNVC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this UNVC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UNVC vs SCHDUNVC vs JEPIUNVC vs OUNVC vs KOUNVC vs MAINUNVC vs JNJUNVC vs ABBVUNVC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.